Caprock Group’s Verona Pharma VRNA Stock Holding History

Caprock Group’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,395	Closed	-$677K	–	1302
2025 Q3	$677K	Buy	+6,395	New	+$668K	0.02%	701
2025 Q1	$380K	Buy	+5,987	New	+$358K	0.01%	811

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Caprock Group's VRNA Position: Q4 2025 in Review

Caprock Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 6,395 shares — an estimated $677K sold.

Caprock Group first reported a position in VRNA in Q1 2025 and held it in 2 quarters. The position peaked at $677K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Caprock Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Caprock Group sold 6,395 Verona Pharma shares in Q4 2025, an estimated $677K.
Caprock Group first reported a position in Verona Pharma in Q1 2025 and held it in 2 quarters.
Caprock Group's Verona Pharma position peaked at $677K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Caprock Group's 13F filing for Q4 2025, filed 28 Jan 2026.